Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.

Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC; Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB.

PLoS Med. 2018 Jul 11;15(7):e1002591. doi: 10.1371/journal.pmed.1002591. eCollection 2018 Jul.

2.

Thin body habitus is a risk factor for active pulmonary tuberculosis, but not for infection.

Chan ED.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):967-968. doi: 10.5588/ijtld.18.0272. No abstract available.

PMID:
29991410
3.

Epidemiologic Evidence of and Potential Mechanisms by Which Second-Hand Smoke Causes Predisposition to Latent and Active Tuberculosis.

Bai X, Aerts SL, Verma D, Ordway DJ, Chan ED.

Immune Netw. 2018 Jun 26;18(3):e22. doi: 10.4110/in.2018.18.e22. eCollection 2018 Jun. Review.

4.

Reduced IFN-γ in Patients with Pulmonary Nontuberculous Mycobacterial Disease: Potentially Multiple Causes.

Chan ED.

Am J Respir Cell Mol Biol. 2018 Jul;59(1):130-131. doi: 10.1165/rcmb.2018-0012LE. No abstract available.

PMID:
29957052
5.

Acquired and genetic host susceptibility factors and microbial pathogenic factors that predispose to nontuberculous mycobacterial infections.

Honda JR, Alper S, Bai X, Chan ED.

Curr Opin Immunol. 2018 Jun 21;54:66-73. doi: 10.1016/j.coi.2018.06.001. [Epub ahead of print] Review.

PMID:
29936307
6.

Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.

Gomes RS, Silva MVT, Dos Santos JC, van Linge C, Reis JM, Teixeira MM, Pinto SA, Dorta ML, Bai X, Chan ED, Dinarello CA, Oliveira MAP, Joosten LAB, Ribeiro-Dias F.

Infect Immun. 2018 Apr 23;86(5). pii: e00796-17. doi: 10.1128/IAI.00796-17. Print 2018 May.

PMID:
29483288
7.

Elucidating the Pathogenesis of Nontuberculous Mycobacterial Lung Disease: Lesson from the Six Blind Men and the Elephant.

Honda JR, Bai X, Chan ED.

Am J Respir Cell Mol Biol. 2018 Feb;58(2):142-143. doi: 10.1165/rcmb.2017-0317ED. No abstract available.

PMID:
29388833
8.

Mycobacterium abscessus Displays Fitness for Fomite Transmission.

Malcolm KC, Caceres SM, Honda JR, Davidson RM, Epperson LE, Strong M, Chan ED, Nick JA.

Appl Environ Microbiol. 2017 Sep 15;83(19). pii: e00562-17. doi: 10.1128/AEM.00562-17. Print 2017 Oct 1.

9.

Treatment of Non-Tuberculous Mycobacterial Lung Disease.

Philley JV, DeGroote MA, Honda JR, Chan MM, Kasperbauer S, Walter ND, Chan ED.

Curr Treat Options Infect Dis. 2016 Dec;8(4):275-296. doi: 10.1007/s40506-016-0086-4. Epub 2016 Oct 11.

10.

IL-32-induced Inflammatory Cytokines Are Selectively Suppressed by α1-antitrypsin in Mouse Bone Marrow Cells.

Lee S, Choi DK, Kwak A, Kim S, Nguyen TT, Gil G, Kim E, Yoo KH, Kim IA, Lee Y, Jhun H, Chan ED, Bai X, Kim H, Kim YS, Kim S.

Immune Netw. 2017 Apr;17(2):116-120. doi: 10.4110/in.2017.17.2.116. Epub 2017 Apr 20.

11.

Complete Genome Sequence of Mycobacterium avium subsp. hominissuis Strain H87 Isolated from an Indoor Water Sample.

Zhao X, Epperson LE, Hasan NA, Honda JR, Chan ED, Strong M, Walter ND, Davidson RM.

Genome Announc. 2017 Apr 20;5(16). pii: e00189-17. doi: 10.1128/genomeA.00189-17.

12.

Nicotine Impairs Macrophage Control of Mycobacterium tuberculosis.

Bai X, Stitzel JA, Bai A, Zambrano CA, Phillips M, Marrack P, Chan ED.

Am J Respir Cell Mol Biol. 2017 Sep;57(3):324-333. doi: 10.1165/rcmb.2016-0270OC.

PMID:
28398760
13.

A 27-Year-Old Man With Acute Severe Low Back Pain and Bilateral Leg Swelling That Prompted Renting a Wheelchair for Mobility.

Williams JG, Phan H, Winston HR, Fugit RV, Graney B, Jamroz B, English B, Chan ED.

Chest. 2017 Feb;151(2):e35-e39. doi: 10.1016/j.chest.2016.08.1459.

PMID:
28183502
14.

MST1R mutation as a genetic cause of Lady Windermere syndrome.

Becker KL, Arts P, Jaeger M, Plantinga TS, Gilissen C, van Laarhoven A, van Ingen J, Veltman JA, Joosten LA, Hoischen A, Netea MG, Iseman MD, Chan ED, van de Veerdonk FL.

Eur Respir J. 2017 Jan 18;49(1). pii: 1601478. doi: 10.1183/13993003.01478-2016. Print 2017 Jan. No abstract available.

15.

Protein Kinase R Mediates the Inflammatory Response Induced by Hyperosmotic Stress.

Farabaugh KT, Majumder M, Guan BJ, Jobava R, Wu J, Krokowski D, Gao XH, Schuster A, Longworth M, Chan ED, Bianchi M, Dey M, Koromilas AE, Ramakrishnan P, Hatzoglou M.

Mol Cell Biol. 2017 Feb 1;37(4). pii: e00521-16. doi: 10.1128/MCB.00521-16. Print 2017 Feb 15.

16.

Correction: Environmental Nontuberculous Mycobacteria in the Hawaiian Islands.

Honda JR, Hasan NA, Davidson RM, Williams MD, Epperson LE, Reynolds PR, Smith T, Iakhiaeva E, Bankowski MJ, Wallace RJ Jr, Chan ED, Falkinham JO 3rd, Strong M.

PLoS Negl Trop Dis. 2016 Dec 2;10(12):e0005200. doi: 10.1371/journal.pntd.0005200. eCollection 2016 Dec.

17.

Complete Genome Sequence of Mycobacterium chimaera Strain AH16.

Hasan NA, Honda JR, Davidson RM, Epperson LE, Bankowski MJ, Chan ED, Strong M.

Genome Announc. 2016 Nov 23;4(6). pii: e01276-16. doi: 10.1128/genomeA.01276-16.

18.

Environmental Nontuberculous Mycobacteria in the Hawaiian Islands.

Honda JR, Hasan NA, Davidson RM, Williams MD, Epperson LE, Reynolds PR, Smith T, Iakhiaeva E, Bankowski MJ, Wallace RJ Jr, Chan ED, Falkinham JO 3rd, Strong M.

PLoS Negl Trop Dis. 2016 Oct 25;10(10):e0005068. doi: 10.1371/journal.pntd.0005068. eCollection 2016 Oct. Erratum in: PLoS Negl Trop Dis. 2016 Dec 2;10 (12 ):e0005200.

19.

Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients.

Walter ND, de Jong BC, Garcia BJ, Dolganov GM, Worodria W, Byanyima P, Musisi E, Huang L, Chan ED, Van TT, Antonio M, Ayorinde A, Kato-Maeda M, Nahid P, Leung AM, Yen A, Fingerlin TE, Kechris K, Strong M, Voskuil MI, Davis JL, Schoolnik GK.

J Infect Dis. 2016 Oct 15;214(8):1205-11. doi: 10.1093/infdis/jiw364. Epub 2016 Aug 17.

20.

A 65-Year-Old Groundskeeper With High Fever, Pulmonary Nodules, and Thoracic Lymphadenopathy.

Foster CL, Badlam J, De Groote MA, Chan ED.

Chest. 2016 Jun;149(6):e191-4. doi: 10.1016/j.chest.2015.12.035.

PMID:
27287596
21.

Curcumin enhances human macrophage control of Mycobacterium tuberculosis infection.

Bai X, Oberley-Deegan RE, Bai A, Ovrutsky AR, Kinney WH, Weaver M, Zhang G, Honda JR, Chan ED.

Respirology. 2016 Jul;21(5):951-7. doi: 10.1111/resp.12762. Epub 2016 Mar 24.

PMID:
27012592
22.

Comparing the temporal colonization and microbial diversity of showerhead biofilms in Hawai'i and Colorado.

Abe J, Alop-Mabuti A, Burger P, Button J, Ellsberry M, Hitzeman J, Morgenstern D, Nunies K, Strother M, Darling-Munson J, Chan YL, Cassady R, Vasconcellos SM, Iseman MD, Chan ED, Honda JR.

FEMS Microbiol Lett. 2016 Feb;363(4). pii: fnw005. doi: 10.1093/femsle/fnw005. Epub 2016 Jan 12.

PMID:
26764424
23.

Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis.

Fox GJ, Mitnick CD, Benedetti A, Chan ED, Becerra M, Chiang CY, Keshavjee S, Koh WJ, Shiraishi Y, Viiklepp P, Yim JJ, Pasvol G, Robert J, Shim TS, Shin SS, Menzies D; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB, Ahuja S, Ashkin D, Avendaño M, Banerjee R, Bauer M, Burgos M, Centis R, Cobelens F, Cox H, D'Ambrosio L, de Lange WCM, DeRiemer K, Enarson D, Falzon D, Flanagan K, Flood J, Gandhi N, Garcia-Garcia L, Granich RM, Hollm-Delgado MG, Holtz TH, Hopewell P, Iseman M, Jarlsberg LG, Kim HR, Lancaster J, Lange C, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Narita M, Nathanson E, Odendaal R, O'Riordan P, Pai M, Palmero D, Park SK, Pena J, Pérez-Guzmán C, Ponce-de-Leon A, Quelapio MID, Quy HT, Riekstina V, Royce S, Salim M, Schaaf HS, Seung KJ, Shah L, Shean K, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Sung SW, Tabarsi P, Tupasi TE, Vargas MH, van Altena R, van der Walt M, van der Werf TS, Westenhouse J, Yew WW.

Clin Infect Dis. 2016 Apr 1;62(7):887-895. doi: 10.1093/cid/ciw002. Epub 2016 Jan 12.

PMID:
26757804
24.

The role of interleukin-32 against tuberculosis.

Bai X, Dinarello CA, Chan ED.

Cytokine. 2015 Dec;76(2):585-587. doi: 10.1016/j.cyto.2015.06.013. Epub 2015 Jul 3.

PMID:
26144292
25.

Pathogenic nontuberculous mycobacteria resist and inactivate cathelicidin: implication of a novel role for polar mycobacterial lipids.

Honda JR, Hess T, Malcolm KC, Ovrutsky AR, Bai X, Irani VR, Dobos KM, Chan ED, Flores SC.

PLoS One. 2015 May 18;10(5):e0126994. doi: 10.1371/journal.pone.0126994. eCollection 2015.

26.

Caspase-3-independent apoptotic pathways contribute to interleukin-32γ-mediated control of Mycobacterium tuberculosis infection in THP-1 cells.

Bai X, Kinney WH, Su WL, Bai A, Ovrutsky AR, Honda JR, Netea MG, Henao-Tamayo M, Ordway DJ, Dinarello CA, Chan ED.

BMC Microbiol. 2015 Feb 21;15:39. doi: 10.1186/s12866-015-0366-z.

27.

Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.

Bai X, Shang S, Henao-Tamayo M, Basaraba RJ, Ovrutsky AR, Matsuda JL, Takeda K, Chan MM, Dakhama A, Kinney WH, Trostel J, Bai A, Honda JR, Achcar R, Hartney J, Joosten LA, Kim SH, Orme I, Dinarello CA, Ordway DJ, Chan ED.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5111-6. doi: 10.1073/pnas.1424302112. Epub 2015 Mar 27.

28.

Epidemiologic link between tuberculosis and cigarette/biomass smoke exposure: Limitations despite the vast literature.

Bishwakarma R, Kinney WH, Honda JR, Mya J, Strand MJ, Gangavelli A, Bai X, Ordway DJ, Iseman MD, Chan ED.

Respirology. 2015 May;20(4):556-68. doi: 10.1111/resp.12515. Epub 2015 Mar 25. Review.

29.

Pathogenesis and risk factors for nontuberculous mycobacterial lung disease.

Honda JR, Knight V, Chan ED.

Clin Chest Med. 2015 Mar;36(1):1-11. doi: 10.1016/j.ccm.2014.10.001. Epub 2014 Nov 6. Review. Erratum in: Clin Chest Med. 2015 Jun;36(2):xvii.

PMID:
25676515
30.

Natural disasters and nontuberculous mycobacteria: a recipe for increased disease?

Honda JR, Bernhard JN, Chan ED.

Chest. 2015 Feb;147(2):304-308. doi: 10.1378/chest.14-0974.

31.

First you have to row a little boat.

Honda JR, Wallace RJ Jr, Chan ED.

Respirology. 2015 Feb;20(2):181-2. doi: 10.1111/resp.12465. Epub 2015 Jan 7. No abstract available.

32.

Tobacco exposure and susceptibility to tuberculosis: is there a smoking gun?

Chan ED, Kinney WH, Honda JR, Bishwakarma R, Gangavelli A, Mya J, Bai X, Ordway DJ.

Tuberculosis (Edinb). 2014 Dec;94(6):544-50. doi: 10.1016/j.tube.2014.08.010. Epub 2014 Sep 28. Review.

PMID:
25305002
33.

A surface with a biomimetic micropattern reduces colonization of Mycobacterium abscessus.

Kim E, Kinney WH, Ovrutsky AR, Vo D, Bai X, Honda JR, Marx G, Peck E, Lindberg L, Falkinham JO 3rd, May RM, Chan ED.

FEMS Microbiol Lett. 2014 Nov;360(1):17-22. doi: 10.1111/1574-6968.12587. Epub 2014 Sep 9.

34.

Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.

Bastos ML, Hussain H, Weyer K, Garcia-Garcia L, Leimane V, Leung CC, Narita M, Penã JM, Ponce-de-Leon A, Seung KJ, Shean K, Sifuentes-Osornio J, Van der Walt M, Van der Werf TS, Yew WW, Menzies D; Collaborative Group for Meta-analysis of Individual Patient Data in MDR-TB.

Clin Infect Dis. 2014 Nov 15;59(10):1364-74. doi: 10.1093/cid/ciu619. Epub 2014 Aug 5.

35.

Plasma LL-37 correlates with vitamin D and is reduced in human immunodeficiency virus-1 infected individuals not receiving antiretroviral therapy.

Honda JR, Connick E, MaWhinney S, Chan ED, Flores SC.

J Med Microbiol. 2014 Jul;63(Pt 7):997-1003. doi: 10.1099/jmm.0.070888-0. Epub 2014 May 12.

36.

Risk factors for the development of pulmonary oil embolism after transcatheter arterial chemoembolization of hepatic tumors.

Wu GC, Chan ED, Chou YC, Yu CY, Hsieh TY, Hsieh CB, Chian CF, Ke FC, Dai YL, Su WL.

Anticancer Drugs. 2014 Sep;25(8):976-81. doi: 10.1097/CAD.0000000000000113.

PMID:
24736105
37.

Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody.

Czaja CA, Merkel PA, Chan ED, Lenz LL, Wolf ML, Alam R, Frankel SK, Fischer A, Gogate S, Perez-Velez CM, Knight V.

Clin Infect Dis. 2014 Mar;58(6):e115-8. doi: 10.1093/cid/cit809. Epub 2013 Dec 11.

38.

Octreotide: a drug often used in the critical care setting but not well understood.

Chan MM, Chan MM, Mengshol JA, Fish DN, Chan ED.

Chest. 2013 Dec;144(6):1937-1945. doi: 10.1378/chest.13-0382. Review.

PMID:
24297127
39.

Patients with non-tuberculous mycobacterial lung disease have elevated transforming growth factor-beta following ex vivo stimulation of blood with live Mycobacterium intracellulare.

Ovrutsky AR, Merkel PA, Schonteich E, Bai X, Kinney W, Iseman MD, Kartalija M, Knight V, Chan ED.

Scand J Infect Dis. 2013 Sep;45(9):711-4. doi: 10.3109/00365548.2013.800947. Epub 2013 Jul 1.

PMID:
23808720
40.

The association between body shape and nontuberculous mycobacterial lung disease.

Talbert J, Chan ED.

Expert Rev Respir Med. 2013 Jun;7(3):201-4. doi: 10.1586/ers.13.23. No abstract available.

PMID:
23734642
41.

Inhibition of nuclear factor-kappa B activation decreases survival of Mycobacterium tuberculosis in human macrophages.

Bai X, Feldman NE, Chmura K, Ovrutsky AR, Su WL, Griffin L, Pyeon D, McGibney MT, Strand MJ, Numata M, Murakami S, Gaido L, Honda JR, Kinney WH, Oberley-Deegan RE, Voelker DR, Ordway DJ, Chan ED.

PLoS One. 2013 Apr 25;8(4):e61925. doi: 10.1371/journal.pone.0061925. Print 2013.

42.

Surgery for MDR-TB?

Chan ED, Iseman MD.

Int J Tuberc Lung Dis. 2013 May;17(5):710. doi: 10.5588/ijtld.13.0104. No abstract available.

PMID:
23575341
43.

Pulse oximetry: understanding its basic principles facilitates appreciation of its limitations.

Chan ED, Chan MM, Chan MM.

Respir Med. 2013 Jun;107(6):789-99. doi: 10.1016/j.rmed.2013.02.004. Epub 2013 Mar 13. Review.

44.

Cooccurrence of free-living amoebae and nontuberculous Mycobacteria in hospital water networks, and preferential growth of Mycobacterium avium in Acanthamoeba lenticulata.

Ovrutsky AR, Chan ED, Kartalija M, Bai X, Jackson M, Gibbs S, Falkinham JO 3rd, Iseman MD, Reynolds PR, McDonnell G, Thomas V.

Appl Environ Microbiol. 2013 May;79(10):3185-92. doi: 10.1128/AEM.03823-12. Epub 2013 Mar 8.

45.

Underlying host risk factors for nontuberculous mycobacterial lung disease.

Chan ED, Iseman MD.

Semin Respir Crit Care Med. 2013 Feb;34(1):110-23. doi: 10.1055/s-0033-1333573. Epub 2013 Mar 4. Review.

PMID:
23460011
46.

Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival.

Malcolm KC, Nichols EM, Caceres SM, Kret JE, Martiniano SL, Sagel SD, Chan ED, Caverly L, Solomon GM, Reynolds P, Bratton DL, Taylor-Cousar JL, Nichols DP, Saavedra MT, Nick JA.

PLoS One. 2013;8(2):e57402. doi: 10.1371/journal.pone.0057402. Epub 2013 Feb 25.

47.

Intravenous immunoglobulin replacement therapy to prevent pulmonary infection in a patient with Good's syndrome.

Wang CH, Chan ED, Perng CL, Chian CF, Chen CW, Perng WC, Su WL.

J Microbiol Immunol Infect. 2015 Apr;48(2):229-32. doi: 10.1016/j.jmii.2012.09.003. Epub 2012 Nov 29.

48.

Need for rigor in design, reporting, and interpretation of transcriptomic biomarker studies.

Walter ND, Bemis L, Edwards M, Ovrutsky AR, Chan ED.

J Clin Microbiol. 2012 Dec;50(12):4190-1; discussion 4192-3. doi: 10.1128/JCM.06775-11. No abstract available.

49.

Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes.

Kartalija M, Ovrutsky AR, Bryan CL, Pott GB, Fantuzzi G, Thomas J, Strand MJ, Bai X, Ramamoorthy P, Rothman MS, Nagabhushanam V, McDermott M, Levin AR, Frazer-Abel A, Giclas PC, Korner J, Iseman MD, Shapiro L, Chan ED.

Am J Respir Crit Care Med. 2013 Jan 15;187(2):197-205. doi: 10.1164/rccm.201206-1035OC. Epub 2012 Nov 9.

50.

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes.

Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH, Hollm-Delgado MG, Keshavjee S, DeRiemer K, Centis R, D'Ambrosio L, Lange CG, Bauer M, Menzies D; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB.

Eur Respir J. 2013 Jul;42(1):156-68. doi: 10.1183/09031936.00134712. Epub 2012 Oct 25.

Supplemental Content

Loading ...
Support Center